These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23905644)

  • 41. Overexpression of PEP-19 suppresses angiotensin II-induced cardiomyocyte hypertrophy.
    Xie YY; Sun MM; Lou XF; Zhang C; Han F; Zhang BY; Wang P; Lu YM
    J Pharmacol Sci; 2014; 125(3):274-82. PubMed ID: 25048017
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
    Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms underlying rate-dependent remodeling of transient outward potassium current in canine ventricular myocytes.
    Xiao L; Coutu P; Villeneuve LR; Tadevosyan A; Maguy A; Le Bouter S; Allen BG; Nattel S
    Circ Res; 2008 Sep; 103(7):733-42. PubMed ID: 18723449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localized cAMP-dependent signaling mediates beta 2-adrenergic modulation of cardiac excitation-contraction coupling.
    Zhou YY; Cheng H; Bogdanov KY; Hohl C; Altschuld R; Lakatta EG; Xiao RP
    Am J Physiol; 1997 Sep; 273(3 Pt 2):H1611-8. PubMed ID: 9321856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.
    Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY
    Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. L-type calcium channel abundance and function with cardiac hypertrophy and failure: a review.
    Mukherjee R; Spinale FG
    J Mol Cell Cardiol; 1998 Oct; 30(10):1899-916. PubMed ID: 9799645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway.
    Dolmetsch RE; Pajvani U; Fife K; Spotts JM; Greenberg ME
    Science; 2001 Oct; 294(5541):333-9. PubMed ID: 11598293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway.
    Wang W; Zhu W; Wang S; Yang D; Crow MT; Xiao RP; Cheng H
    Circ Res; 2004 Oct; 95(8):798-806. PubMed ID: 15375008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy.
    Wang GJ; Wang HX; Yao YS; Guo LY; Liu P
    Braz J Med Biol Res; 2012 Nov; 45(11):1045-51. PubMed ID: 22832601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?
    Anderson ME
    Trends Cardiovasc Med; 2004 May; 14(4):152-61. PubMed ID: 15177266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced Ca2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway.
    Yatani A; Honda R; Tymitz KM; Lalli MJ; Molkentin JD
    J Mol Cell Cardiol; 2001 Feb; 33(2):249-59. PubMed ID: 11162130
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Oxidative stress and calcium/calmodulin-dependent protein kinase II contribute to the development of sustained β adrenergic receptor-stimulated cardiac hypertrophy in rats].
    Liu YL; Liu B; Qu YY; Chai HJ; Li R; Zhang L
    Sheng Li Xue Bao; 2013 Feb; 65(1):1-7. PubMed ID: 23426507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling.
    Chen Y; Yuan J; Jiang G; Zhu J; Zou Y; Lv Q
    Mol Med Rep; 2017 Oct; 16(4):4545-4552. PubMed ID: 28849081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes.
    Lu YM; Shioda N; Han F; Moriguchi S; Kasahara J; Shirasaki Y; Qin ZH; Fukunaga K
    Biochem Pharmacol; 2007 Dec; 74(12):1727-37. PubMed ID: 17888407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
    Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
    Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
    Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.
    Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR
    Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.
    Zhu WZ; Wang SQ; Chakir K; Yang D; Zhang T; Brown JH; Devic E; Kobilka BK; Cheng H; Xiao RP
    J Clin Invest; 2003 Mar; 111(5):617-25. PubMed ID: 12618516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction of alpha1-adrenoceptor subtypes with different G proteins induces opposite effects on cardiac L-type Ca2+ channel.
    O-Uchi J; Sasaki H; Morimoto S; Kusakari Y; Shinji H; Obata T; Hongo K; Komukai K; Kurihara S
    Circ Res; 2008 Jun; 102(11):1378-88. PubMed ID: 18467629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac Remodeling and Disease: SOCE and TRPC Signaling in Cardiac Pathology.
    Eder P
    Adv Exp Med Biol; 2017; 993():505-521. PubMed ID: 28900930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.